Tags:BioTechCommerceDevelopmentDrugEngineeringIndustryInformationLifeManufacturingMediaProductResearchScienceServiceTechnology
Selexis SA, a JSR Life Sciences Company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative biologic medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 130 drug products in clinical development and the manufacture of eight commercial products. As part of a comprehensive drug development process, the Company’s technologies – offered under flexible, customized contractual agreements – shorten development timelines and reduce manufacturing risks. More information is available at www.selexis.com.
Likes
2401
Location: Switzerland, Geneva, Arare
Member count: 51-200
Phone: +41 22 308 93 60
Founded date: 2001

Investors 1

Mentions in press and media 17

DateTitleDescriptionCategoryAuthorSource
20.10.2020New manage... Aktiia SA is a Swiss-US star...Expansion-startuptic...
20.10.2020New manage...Aktiia SA is a Swiss-US start-...--startuptic...
17.10.2019Af­ter 13%...→ As­traZeneca-part­nered Fren...-Kathy Wongendpts.com...
16.04.2018Selexis in... In May 2017, Selexis opened ...Expansion ...-startuptic...
29.11.2017Venture Ki... Established in 2007, Venture...Background...-startuptic...
27.06.2017Mi­to­coni...→ Mi­to­conix has a neu­rode­g...-Shehla Sha...endpts.com...
21.02.2017Selexis In... Selexis SA announced today i...Success-startuptic...
09.01.2015First Sele... “This market approval repres...--startuptic...
25.06.2014Developing... Preliminary data from the Co...--startuptic...
06.12.2013JHL Biotec... The alliance leverages the s...--startuptic...
Show more